[GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers].
Allergic diseases represent a major health problem in Europe. They are increasing in prevalence, severity and costs. GA2LEN (Global Allergy and Asthma European Network), an FP6 Network of Excellence, was created in 2005 as a vehicle to ensure excellence in research bringing together research and clinical institutions to combat fragmentation in the European research area and to tackle allergy as a whole. GA2LEN benefited greatly from the voluntary efforts of researchers who are strongly committed to this model of pan-European collaboration. The network was organized in order to increase networking for scientific projects in allergy and asthma around Europe and to make GA2LEN the world leader in the field. Besides these activities, research has been jointly made and the first papers are being published. GA2LEN achievements in general can be grouped as those for a durable infrastructure built up during the project phase those which are project-related work based on these novel infrastructures, and the development and implementations of guidelines. The major achievements of GA2LEN are reported in this paper.
Wöhrl
Stefan
S
Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases (DIAID), Medical University of Vienna, Vienna, Austria.
Radon
Katja
K
Ring
Johannes
J
Moritz
Katharina
K
Akdis
Cezmi
C
Burney
Peter
P
Van Cauwenberge
Paul
P
Bousquet
Jean
J
Zuberbier
Torsten
T
D001249:Asthma / Q000175:diagnosis* / Q000628:therapy*; D001317:Austria; D019058:Community Networks / Q000458:organization & administration*; D005858:Germany; D006967:Hypersensitivity / Q000175:diagnosis* / Q000628:therapy*; D017146:Models, Organizational; D013557:Switzerland